LTR Pharma (ASX:LTP) said its joint venture partner, Restorative Sexual Health Clinic, launched an online healthcare platform ahead of schedule for Australian men, according to a Thursday filing with the Australian bourse.
The platform will provide evidence-based care for erectile dysfunction through telehealth consultations, the filing said.
The clinical-stage pharmaceutical company also noted that the platform provides an additional channel for delivering Spontan, its intranasal spray treatment for erectile dysfunction.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.